21 November 2018

Paul Scheepers has been invited as contributing author to the flagship Report “Science for Disaster Risk Management 2020 -  Acting today, Protecting Tomorrow”.

Report “Science for Disaster Risk Management 2020 -  Acting today, Protecting Tomorrow”.
This EU report is prepared by the Disaster Risk Management Knowledge Centre (DRMKC) at the Joint Research Centre, the scientific service of the European Commission. His contribution will address the hazards and related vulnerability that mostly threat human lives in the EU, either by death, injury or other health damage.
Paul Scheepers was invited based on several publications on the use of human biological monitoring in response to chemical incidents. His publications supported the decision of the federal government in Belgium to initiate a human biomonitoring study in the aftermath of the train crash in Wetteren. The use of biomarkers in the disaster risk management setting is considered an important innovative methodology that will support human health risk assessment during the aftermath of a disaster.
This authorship will complement his involvement as rapid risk assessment expert on chemical threats for the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) of DG Health and Food Safety that is mandated by the European Commission to provide within a short time-frame (36 hours) public health risk assessment in case of cross-border chemical threats in the European Union.

 

Related news items


650,000 Euro funding for research into the phasing out of medication for leukaemia patients

30 July 2020

With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.

read more

Increased role of patients after bowel cancer treatment

30 July 2020

Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.

read more

ERC Proof of Concept grant received by Ronald van Rij

30 July 2020

Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.

read more

Hypatia fellowship Call is open

30 July 2020

The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.  

read more

Mihai Netea and colleagues published two papers back-to-back in The Journal of Clinical Investigation. 

29 July 2020

These back-to-back articles investigated the effect of BCG vaccination on trained immunity. The first article shows that BCG vaccination inhibits systemic inflammation, depending on gender. The second article demonstrates that the circadian rhythm influences the induction of trained immunity.

read more

Genetic mutation reveals how coronavirus strikes TLR7 plays essential role in disease process

28 July 2020

''Does a congenital immune defect play an important role in the defense against Coronavirus?'' This was published by Cas van der Made, Frank van der Veerdonk and Alexander Hoischen.

read more